Last update 08 May 2025

AM-3301

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [1]
Target-
Action
inhibitors
Mechanism
Mediator release inhibitors
Therapeutic Areas
Immune System DiseasesInfectious DiseasesDigestive System Disorders+ [2]
Active Indication-
Inactive Indication
Colitis, UlcerativeRhinitis, Allergic
Originator Organization
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.
Active Organization-
Inactive Organization
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.Amalyte Pharmaceuticals LLC
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with AM-3301
CTRI/2010/091/000444
/ CompletedPhase 2
Multi-center, randomized, double-blind, placebo-controlled study of two dosages of AM3301 for add-on treatment of mild to moderate active ulcerative colitis
EUCTR2004-000684-10-AT
/ Not yet recruitingNot Applicable
A randomised, double-blind, placebo-controlled crossover study to investigate the efficacy and safety of three doses of ME3301 in patients with seasonal allergic rhinitis during allergen challenge in the Vienna Challenge Chamber
100 Clinical Results associated with AM-3301
Login to view more data
100 Translational Medicine associated with AM-3301
Login to view more data
100 Patents (Medical) associated with AM-3301
Login to view more data
100 Deals associated with AM-3301
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colitis, UlcerativePhase 2-
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.
-
Colitis, UlcerativePhase 2
United States
Amalyte Pharmaceuticals LLC
-
Colitis, UlcerativePhase 2
India
Amalyte Pharmaceuticals LLC
-
Rhinitis, AllergicPhase 2
United States
Amalyte Pharmaceuticals LLC
-
Rhinitis, AllergicPhase 2-
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free